The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas, TAYFUN; Pestereli, Elif; ŞİMŞEK, TAYUP; Bozkurt, SELEN; ERDOĞAN, GÜLGÜN; Karaveli, Seyda

doi:10.4103/0973-1482.172130

The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas T., Pestereli E., ŞİMŞEK T., Bozkurt S., ERDOĞAN G., Karaveli S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, no.3, pp.587-592, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 14 Issue: 3
Publication Date: 2018
Doi Number: 10.4103/0973-1482.172130
Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.587-592
Keywords: High-grade serous carcinoma, serous tubal intraepithelial carcinoma, survival, PROPHYLACTIC OOPHORECTOMY SPECIMENS, CANCER, ADENOCARCINOMA, FIMBRIA, TUMORS, WOMEN, P53
Akdeniz University Affiliated: Yes

Abstract

Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associated with clinical outcomes in a nonselected (unknown BRCA status) cohort of patients with a high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, and peritoneum.